Biology of Blood and Marrow Transplantation
Volume 14, Issue 12 , Pages 1356-1364 , December 2008

Autologous Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T Cell Lymphoma: A Multinational, Multicenter, Matched Controlled Study

  • Jeeyun Lee

      Affiliations

    • Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • ,
  • Wing-Yan Au

      Affiliations

    • Department of Medicine, Queen Mary Hospital, Hong Kong
    • ,
  • Min Jae Park

      Affiliations

    • Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • ,
  • Junji Suzumiya

      Affiliations

    • First Department of Internal Medicine, Fukuoka University School of Medicine, Fukuoka, Japan
    • ,
  • Shigeo Nakamura

      Affiliations

    • Department of Pathology, Nagoya University School of Medicine, Nagoya, Japan
    • ,
  • Jun-Ichi Kameoka

      Affiliations

    • Department of Rheumatology and Haematology, Tohoku University School of Medicine, Sendai, Japan
    • ,
  • Chikara Sakai

      Affiliations

    • Department of Hematology and Oncology, Chiba Cancer Center, Chiba, Japan
    • ,
  • Kazuo Oshimi

      Affiliations

    • Department of Hematology, Juntendo University, Tokyo, Japan
    • ,
  • Yok-Lam Kwong

      Affiliations

    • Department of Medicine, Queen Mary Hospital, Hong Kong
    • ,
  • Raymond Liang

      Affiliations

    • Department of Medicine, Queen Mary Hospital, Hong Kong
    • ,
  • Harry Yiu

      Affiliations

    • Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong
    • ,
  • Kam-Hung Wong

      Affiliations

    • Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong
    • ,
  • Hoi-Ching Cheng

      Affiliations

    • Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong
    • ,
  • Baek-Yeol Ryoo

      Affiliations

    • Department of Hematology-Oncology, Korea Cancer Center Hospital, Seoul, Korea
    • ,
  • Cheolwon Suh

      Affiliations

    • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    • ,
  • Young Hyeh Ko

      Affiliations

    • Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • ,
  • Kihyun Kim

      Affiliations

    • Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • ,
  • Jae-Won Lee

      Affiliations

    • Department of Statistics, Korea University, Seoul, Korea
    • ,
  • Won Seog Kim

      Affiliations

    • Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • Corresponding Author InformationCorrespondence and reprint requests: Won Seog Kim, MD, PhD, Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong Kangnam-Gu, Seoul 135-710 Korea.
    • ,
  • Ritsuro Suzuki

      Affiliations

    • Department of Hematopoietic Stem Cell Transplantation Data Management, Nagoya University School of Medicine, Nagoya, Japan
    • Corresponding Author InformationRitsuro Suzuki, MD, PhD, Department of Hematopoietic Stem Cell Transplantation Data Management, Nagoya University School of Medicine, 1-1-20 Daiko-Minami, Higashi-Ku, Nagoya 461-0047, Japan.

  • Image Result

    Survival of all patients (A) and survival according to HSCT (B).

    Survival of all patients (A) and survival according to HSCT (B).

  • Image Result

    A) OS according to HSCT in CR patients, B) Impact of HSCT on survival of the low NKIPI group (CR), C) Impact of HSCT on survival of the high NKIPI group (non-CR).

    A) OS according to HSCT in CR patients, B) Impact of HSCT on survival of the low NKIPI group (CR), C) Impact of HSCT on survival of the high NKIPI group (non-CR).

  • Image Result

    A) OS according to HSCT in non-CR patients, B) Impact of HSCT on survival of the low NKIPI group (non-CR), C) Impact of HSCT on survival of the high NKIPI group (non-CR).

    A) OS according to HSCT in non-CR patients, B) Impact of HSCT on survival of the low NKIPI group (non-CR), C) Impact of HSCT on survival of the high NKIPI group (non-CR).

 J. Lee and W.Y. Au contributed equally as first authors.

 The authors have no conflicts of interest to declare.

 Financial disclosure: See Acknowledgments on page 1364.

PII: S1083-8791(08)00405-9

doi: 10.1016/j.bbmt.2008.09.014

Biology of Blood and Marrow Transplantation
Volume 14, Issue 12 , Pages 1356-1364 , December 2008

Article Tools

* Image Usage & Resolution